From: CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation
Puromycin concentration
Non-transfected cell viability %
0 μg/mL
100
3 μg/mL
6 μg/mL
85
9 μg/mL
30
12 μg/mL
0
15 μg/mL